Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Status:
Terminated
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The study investigates the safety and efficacy of PMX-60056 for the Reversal of Heparin in
Patients Undergoing Percutaneous Coronary Intervention (PCI)